Brief: Allergy Therapeutics Raises Gross Proceeds Of About £40.75 Mln Via Equity Financing
Oct 13 (Reuters) - Allergy Therapeutics PLC AGY.L :
* RESULT OF OPEN OFFER AND SUBSCRIPTION
* CONDITIONALLY RAISED TOTAL GROSS PROCEEDS OF APPROXIMATELY
£40.75 MILLION THROUGH EQUITY FINANCING WHICH WAS ANNOUNCED ON 6
APRIL
Source text for Eikon: ID:nRSM9983Pa
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman